Metraipolis › archive › dc_b1063dccc010

MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify — Europe PMC PPR:PPR1039718

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR1039718
DOI
10.1101/2025.06.17.25329143
License (as archived)
CC0-1.0
Archived
2026-10-06T09:50:57.127Z
SHA-256 of the archived text
72daec5dbbfa28fa8e315039dd947bdaeb618f6c34d257c3d0b055a0fe4ee84e
Stable URL of this page
https://metraipolis.com/documento/dc_b1063dccc010

How to cite

MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify — Europe PMC PPR:PPR1039718 — Europe PMC, https://europepmc.org/article/PPR/PPR1039718 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_b1063dccc010 (Metraipolis archive dc_b1063dccc010, sha256 72daec5dbbfa28fa8e315039dd947bdaeb618f6c34d257c3d0b055a0fe4ee84e)
BibTeX
@misc{dcb1063dccc010,
  title = {MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify — Europe PMC PPR:PPR1039718},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1039718},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_b1063dccc010; sha256 72daec5dbbfa28fa8e315039dd947bdaeb618f6c34d257c3d0b055a0fe4ee84e},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR1039718. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Maturity Onset Diabetes of the Young (MODY) can present after the age of 40yrs, but its prevalence, clinical characteristics, and the utility of simple clinical features for selecting cases in this age group remain poorly defined. We analysed whole-exome and clinical data from 51,619 individuals with diabetes diagnosed after 40 years of age from two large cohorts: the UK Biobank (n = 25,012) and the US health system MyCode cohort (n = 26,607). The prevalence of MODY due to pathogenic variants in the ten most common genes was 1 in 191 (0.52%) and 1 in 633 (0.16%) in the UK and US cohorts. For subtypes with treatment implications ( GCK, HNF1A, HNF4A, ABCC8, KCNJ11 ), prevalence was 1 in 234 and 1 in 935, respectively. GCK -MODY was most common, followed by HNF4A and lower-penetrance RFX6 . Clinical features of MODY overlapped with both insulin-treated and non-insulin-treated non-MODY diabetes. Applying simple clinical criteria only increased the MODY diagnosis to 2.64% and 0.87% but missed over 86% of cases. MODY is more common than expected in later-onset diabetes but remains difficult to identify using clinical features alone. Further research is needed to develop more effective strategies for selecting individuals with later-onset diabetes for genetic testing. Article Highlights: Why did we undertake this study?: MODY can present later in life, and diagnosis can enable precision treatment. However, individuals with later-onset diabetes are rarely tested. What specific question did we ask?: How common is MODY in people diagnosed with diabetes after 40 years, and can they be identified clinically? What did we find?: MODY affects 1 in 191 to 633 individuals with diabetes onset after 40 years, but clinical features alone cannot reliably identify them. What are the implications?: MODY is relatively common in later-onset diabetes but difficult to detect clinically, limiting routine genetic testing in this group.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: medRxiv, 2025 (prima pubblicazione 2025-06-18).
Identificativi: DOI 10.1101/2025.06.17.25329143.
Pagina: https://europepmc.org/article/PPR/PPR1039718 — https://doi.org/10.1101/2025.06.17.25329143. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-06T09:43:38.069Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.